Vitura Health Limited (ASX:VIT)
Australia · Delayed Price · Currency is AUD 0.0570
+0.0020 (3.51%)
Jan 30, 2026, 4:10 PM AEST
Vitura Health Revenue
In the fiscal year ending June 30, 2025, Vitura Health had annual revenue of 124.04M AUD with 0.13% growth. Vitura Health had revenue of 61.36M in the half year ending June 30, 2025, with 2.81% growth.
Revenue
124.04M
Revenue Growth
+0.13%
P/S Ratio
0.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 124.04M | 166.10K | 0.13% |
| Jun 30, 2024 | 123.87M | 6.53M | 5.56% |
| Jun 30, 2023 | 117.34M | 50.35M | 75.16% |
| Jun 30, 2022 | 66.99M | 45.28M | 208.54% |
| Jun 30, 2021 | 21.71M | 21.59M | 17,431.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vita Life Sciences | 85.60M |
| Medical Developments International | 39.06M |
| Little Green Pharma | 38.49M |
| Next Science | 33.66M |
| IDT Australia | 19.77M |
| ECS Botanics Holdings | 19.36M |
| Peak Processing | 15.49M |
| Cann Group | 13.25M |